WeVote
Log In

Bill

Bill

SB 130

NO COST-SHARING OF CERTAIN DRUGS

2026 Regular Session

SB 130 eliminates copayments and deductibles for specified prescription drugs in New Mexico to improve medication access, shifting costs to insurers or state programs.

action postponed indefinitely
#health&healthfacilities
0
WeVote Research Nonpartisan
Bill Summary · SB 130

Legislative bill overview

SB 130 prohibits cost-sharing (copayments, coinsurance, and deductibles) for certain prescription drugs in New Mexico. The bill appears designed to reduce financial barriers to medication access by eliminating out-of-pocket costs for specified drugs, though the bill summary does not detail which drugs are covered.

Why is this important

Medication cost-sharing is a significant barrier to treatment adherence, particularly for chronic conditions and low-income populations. Eliminating cost-sharing could improve health outcomes but raises questions about implementation costs, which drug classes qualify, and how the state or insurers will absorb these expenses.

Potential points of contention

  • Fiscal impact: The bill has been referred to the Tax, Business and Transportation Committee, suggesting cost concerns. Eliminating cost-sharing reduces revenue collection and increases costs for state budgets, insurers, or both—funding mechanisms are unclear
  • Drug selection criteria: The bill's language "certain drugs" is vague; determining which medications qualify could be contentious and may exclude drugs patients need
  • Insurance market effects: Broader cost-sharing elimination could increase overall drug utilization and insurance premiums, potentially shifting costs to other consumers or limiting coverage options

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.